Reminder: Join Us For an Interactive Webinar on New Model for Drug Development

The Myelin Repair Foundation, Ewing Marion Kauffman Foundation, Pioneer Portfolio of the Robert Wood Johnson Foundation, and the Scott Cook & Signe Ostby Foundation invite you to participate in an interactive Webinar to discuss a new drug development model employed by the Myelin Repair Foundation with the potential to cut years from the drug development timeline, saving lives and money.

As the nation deals with spiraling drug costs and an urgent need for new treatments, the Myelin Repair Foundation has pioneered a holistic approach to multiple sclerosis drug development that bridges the gap between the promising discoveries made in academic laboratories and big-pharmaceutical drug research and development. The approach shows early promise in cutting development costs and shaving years off of the time it takes to move a drug from basic science to patient therapy.

The Myelin Repair Foundation's approach will not only benefit the millions living with MS but also provides a new source of high-quality drug targets for the dwindling biopharma pipelines. Learn why the Ewing Marion Kauffman Foundation, Pioneer Portfolio of the Robert Wood Johnson Foundation, and the Scott Cook & Signe Ostby Foundation are investing in MRF's unique approach, its potential to accelerate the drug development process, and why this should call attention to the demand for a new research paradigm. The session will include an interactive Q&A portion where participants can direct questions to participating panelists.